Literature DB >> 20602180

Solitary lymphangioleiomyoma of pancreas mimicking pancreatic pseudocyst--a case report.

Meeta Singh1, Vijay Saroha, Rachna Wadhwa, Nita Khurana, A K Kakkar.   

Abstract

INTRODUCTION: Lymphangioleiomyomatosis (LAM) is a rare disease characterized by proliferation of morphologically distinguishable smooth muscle cells in the lymphatics and lymph nodes of the pulmonary parenchyma in most cases. Extrapulmonary LAM is a rare condition and is found to occur concurrently, before or after pulmonary LAM, and show strong association with tuberous sclerosis. DISCUSSION: The literature regarding extrapulmonary LAM without associated pulmonary LAM is limited due to the extreme rarity of the cases. We hereby describe clinical, pathological and radiological features of primary pancreatic LAM presenting clinicoradiologically as pseudocyst of pancreas in a 43-year-old lady.
CONCLUSION: The present case is unique as LAM in pancreas without associated pulmonary LAM has never been reported in the literature before.

Entities:  

Mesh:

Year:  2012        PMID: 20602180     DOI: 10.1007/s12029-010-9183-7

Source DB:  PubMed          Journal:  J Gastrointest Cancer


  13 in total

1.  Generalised lymphangioleiomyomatosis presenting as a retroperitoneal tumour.

Authors:  K A Gawad; W T Knoefel; J R Izbicki; S Schröder; C E Broelsch
Journal:  Eur J Surg       Date:  1996-07

Review 2.  PEComa: what do we know so far?

Authors:  J L Hornick; C D M Fletcher
Journal:  Histopathology       Date:  2006-01       Impact factor: 5.087

Review 3.  Extrapulmonary lymphangioleiomyomatosis (LAM): clinicopathologic features in 22 cases.

Authors:  K Matsui; A Tatsuguchi; J Valencia; Z x Yu; J Bechtle; M B Beasley; N Avila; W D Travis; J Moss; V J Ferrans
Journal:  Hum Pathol       Date:  2000-10       Impact factor: 3.466

Review 4.  Lymphangioleiomyomatosis.

Authors:  S R Johnson
Journal:  Eur Respir J       Date:  2006-05       Impact factor: 16.671

5.  Chromosome 16 loss of heterozygosity in tuberous sclerosis and sporadic lymphangiomyomatosis.

Authors:  J Yu; A Astrinidis; E P Henske
Journal:  Am J Respir Crit Care Med       Date:  2001-10-15       Impact factor: 21.405

6.  Pancreatic PEComa (sugar tumor): MDCT and EUS features.

Authors:  Juan C Baez; Jean M Landry; Jonathan R Saltzman; Xiaohua Qian; Michael J Zinner; Koenraad J Mortelé
Journal:  JOP       Date:  2009-11-05

7.  A case of lymphangioleiomyomatosis originated in the pelvic cavity.

Authors:  Jung-Mi Han; Kyung-Hee Lee; Sung-Joo Kim; Chae-Chun Rhim; Young-Han Park; Jung-Bae Kang; Sun-Young Jeon
Journal:  J Gynecol Oncol       Date:  2008-09-30       Impact factor: 4.401

Review 8.  Localized retroperitoneal lymphangioleiomyomatosis mimicking malignancy. A case report and review of the literature.

Authors:  Vilkesh R Jaiswal; Julie Baird; Jason Fleming; David Scott Miller; Suash Sharma; Kyle Molberg
Journal:  Arch Pathol Lab Med       Date:  2003-07       Impact factor: 5.534

Review 9.  Lymphangioleiomyomatosis: a clinical update.

Authors:  Francis X McCormack
Journal:  Chest       Date:  2008-02       Impact factor: 9.410

Review 10.  PEComas: the past, the present and the future.

Authors:  Guido Martignoni; Maurizio Pea; Daniela Reghellin; Giuseppe Zamboni; Franco Bonetti
Journal:  Virchows Arch       Date:  2007-12-14       Impact factor: 4.064

View more
  2 in total

1.  Solitary extrapulmonary lymphangioleiomyomatosis of the liver: A case report and literature review.

Authors:  Weiwei Fu; Yujun Li; Hong Li; Ping Yang; Xiaoming Xing
Journal:  Exp Ther Med       Date:  2016-07-05       Impact factor: 2.447

2.  Perivascular Epithelial Cell Tumor of the Pancreas Diagnosed Preoperatively by Endoscopic Ultrasound-guided Fine-needle Aspiration.

Authors:  Konomu Uno; Shuya Shimizu; Katsumi Hayashi; Tomonori Yamada; Atsunori Kusakabe; Hiroshi Kanie; Yusuke Mizuno; Kazuhiro Nagao; Hiromichi Araki; Tadashi Toyohara; Takeo Kanda; Kohei Okayama; Takanori Suzuki; Shun Miyagishima; Takashi Watanabe; Takahiro Nakazawa
Journal:  Intern Med       Date:  2019-06-07       Impact factor: 1.271

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.